Related Experiment Video
Updated: Dec 29, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Plasmid-mediated metronidazole resistance in Clostridioides difficile
Ilse M Boekhoud1,2,3, Bastian V H Hornung1,4, Eloisa Sevilla5
1Department of Medical Microbiology, Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Abstract:
Metronidazole was until recently used as a first-line treatment for potentially life-threatening Clostridioides difficile (CD) infection. Although cases of metronidazole resistance have been documented, no clear mechanism for metronidazole resistance or a role for plasmids in antimicrobial resistance has been described for CD. Here, we report genome sequences of seven susceptible and sixteen resistant CD isolates from human and animal sources, including isolates from a patient with recurrent CD infection by a PCR ribotype (RT) 020 strain, which developed resistance to metronidazole over the course of treatment (minimal inhibitory concentration [MIC] = 8 mg L-1). Metronidazole resistance correlates with the presence of a 7-kb plasmid, pCD-METRO. pCD-METRO is present in toxigenic and non-toxigenic resistant (n = 23), but not susceptible (n = 563), isolates from multiple countries. Introduction of a pCD-METRO-derived vector into a susceptible strain increases the MIC 25-fold. Our finding of plasmid-mediated resistance can impact diagnostics and treatment of CD infections.
Insights
A newly discovered plasmid, pCD-METRO, is responsible for metronidazole resistance in Clostridioides difficile (CD) infections. This finding impacts how we diagnose and treat this potentially life-threatening bacterial infection.
Area of Science:
- Microbiology
- Genomics
- Antimicrobial Resistance
Background:
- Metronidazole was a primary treatment for Clostridioides difficile (CD) infections.
- Mechanisms of metronidazole resistance in CD were previously unclear, with no described role for plasmids.
Purpose of the Study:
- To investigate the genetic basis of metronidazole resistance in Clostridioides difficile.
- To identify potential mechanisms and genetic elements involved in antimicrobial resistance.
Main Methods:
- Genome sequencing of susceptible and resistant CD isolates from human and animal sources.
- Plasmid analysis and characterization, including the identification of pCD-METRO.
- Introduction of plasmid-derived vectors into susceptible strains to assess resistance transfer.
Main Results:
- Metronidazole resistance in CD isolates correlates with the presence of a 7-kb plasmid, designated pCD-METRO.
- This plasmid was found in resistant isolates from multiple countries but absent in susceptible ones.
- Introducing pCD-METRO into a susceptible strain significantly increased metronidazole resistance (25-fold).
Conclusions:
- Plasmid-mediated transfer is a key mechanism for metronidazole resistance in Clostridioides difficile.
- The identification of pCD-METRO has significant implications for the diagnostics and treatment strategies for CD infections.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Plasmids

